About Global Exponential Technologies (GxT

The startup develops RegWriter™, an AI-augmented authoring platform that streamlines regulatory submission workflows for medical device and biopharma professionals by standardizing templates and reducing manual effort. Their solutions address inefficiencies in regulatory affairs, clinical research, and quality management, ultimately lowering costs and improving submission quality.

```xml <problem> The creation of regulatory submissions for medical devices and biopharmaceuticals is often inefficient, relying on manual processes and inconsistent templates. This leads to increased costs, delays, and potential errors in documentation, hindering the timely approval of new products. </problem> <solution> RegWriter™ is an AI-augmented authoring platform designed to streamline regulatory submission workflows for medical device and biopharma professionals. The platform standardizes templates and automates key aspects of the authoring process, reducing manual effort and improving efficiency. By leveraging AI, RegWriter™ helps to ensure consistency, accuracy, and compliance with regulatory requirements, ultimately lowering costs and accelerating the submission process. The platform's secure and scalable architecture allows organizations to adapt and grow while maintaining data integrity and regulatory adherence. </solution> <features> - AI-augmented authoring tools for automated content generation and review - Standardized templates aligned with industry best practices and regulatory guidelines - Collaborative workspace for real-time document editing and version control - Automated categorization of post-market complaints using MDCG-recommended IMDRF Annex terminology (SmartComplaints™) - Secure and scalable architecture to support growing organizations </features> <target_audience> The primary target audience includes regulatory affairs professionals, clinical researchers, and quality management teams within medical device and biopharmaceutical companies. </target_audience> ```

What does Global Exponential Technologies (GxT do?

When was Global Exponential Technologies (GxT founded?

Global Exponential Technologies (GxT was founded in 2022.

Founded

2022

Employees

5 employees

Global Exponential Technologies (GxT

Founded 20225500+ followers3/10 TractionRelative Traction Score based on online presence metrics compared to companies in the same age group.

Updated 3 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

The creation of regulatory submissions for medical devices and biopharmaceuticals is often inefficient, relying on manual processes and inconsistent templates. This leads to increased costs, delays, and potential errors in documentation, hindering the timely approval of new products.

Solution

RegWriter™ is an AI-augmented authoring platform designed to streamline regulatory submission workflows for medical device and biopharma professionals. The platform standardizes templates and automates key aspects of the authoring process, reducing manual effort and improving efficiency. By leveraging AI, RegWriter™ helps to ensure consistency, accuracy, and compliance with regulatory requirements, ultimately lowering costs and accelerating the submission process. The platform's secure and scalable architecture allows organizations to adapt and grow while maintaining data integrity and regulatory adherence.

Target Audience

The primary target audience includes regulatory affairs professionals, clinical researchers, and quality management teams within medical device and biopharmaceutical companies.

Features

AI-augmented authoring tools for automated content generation and review
Standardized templates aligned with industry best practices and regulatory guidelines
Collaborative workspace for real-time document editing and version control
Automated categorization of post-market complaints using MDCG-recommended IMDRF Annex terminology (SmartComplaints™)
Secure and scalable architecture to support growing organizations